These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20551389)

  • 41. Entrapment of right atrial pacemaker lead by patent foramen ovale closure device: successful percutaneous salvage.
    Meltser H; Hoyer MH; Kalaria VG
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):593-6. PubMed ID: 15937955
    [No Abstract]   [Full Text] [Related]  

  • 42. Cardiac magnetic resonance imaging and the WATCHMAN device.
    Hong SN; Rahimi A; Kissinger KV; Pedrosa I; Manning WJ; O'Halloran TD
    J Am Coll Cardiol; 2010 Jun; 55(24):2785. PubMed ID: 20538174
    [No Abstract]   [Full Text] [Related]  

  • 43. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CASE 5--2012: incidentally detected patent foramen ovale in a patient undergoing aortic valve replacement: to close or not to close?
    Misra S; Dash PK; Koshy T; Varma PK; Pal S; Dineshkumar US; Banayan J; Capdeville M
    J Cardiothorac Vasc Anesth; 2012 Aug; 26(4):721-8. PubMed ID: 22652000
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report.
    Motreff P; Dauphin C; Souteyrand G
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):412-6. PubMed ID: 18288748
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Patent foramen ovale, systemic embolization, and closure.
    Holmes DR; Cohen HA; Ruiz C
    Curr Probl Cardiol; 2009 Oct; 34(10):483-530. PubMed ID: 19733784
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Backward Migration of a MitraClip Through a Patent Transseptal Orifice: The Salmon Syndrome.
    Caussin C; Diakov C; Dervanian P; Amabile N
    JACC Cardiovasc Interv; 2015 Dec; 8(14):1907-8. PubMed ID: 26604053
    [No Abstract]   [Full Text] [Related]  

  • 48. Patent oval foramen transcatheter closure: results of a strategy based on tailoring the device to the specific patient's anatomy.
    Rigatelli G; Dell'Avvocata F; Ronco F; Giordan M; Cardaioli P
    Cardiol Young; 2010 Apr; 20(2):144-9. PubMed ID: 20219151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Closing a door.
    Butman S
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):396-7. PubMed ID: 18288738
    [No Abstract]   [Full Text] [Related]  

  • 50. Large left atrial thrombus formation despite warfarin therapy after device closure of a patent foramen ovale.
    Cetta F; Arruda MJ; Graham LC
    Catheter Cardiovasc Interv; 2003 Jul; 59(3):396-8. PubMed ID: 12822169
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double atrial septum with persistent interatrial space and transient ischaemic attack.
    Seyfert H; Bohlscheid V; Bauer B
    Eur J Echocardiogr; 2008 Sep; 9(5):707-8. PubMed ID: 18490273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of stroke in patients with patent foramen ovale.
    Mattle HP; Meier B; Nedeltchev K
    Int J Stroke; 2010 Apr; 5(2):92-102. PubMed ID: 20446943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Atrial fibrillation following transcatheter closure of patent foramen ovale.
    Ganado CC; Felice H; Aquilina O; Xuereb R; Tilney T; Fenech A; Grech V
    Hellenic J Cardiol; 2008; 49(1):59. PubMed ID: 18350785
    [No Abstract]   [Full Text] [Related]  

  • 54. Patent foramen ovale closure with the Intrasept occluder: Complete 6-56 months follow-up of 247 patients after presumed paradoxical embolism.
    Spies C; Timmermanns I; Reissmann U; van Essen J; Schräder R
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):390-5. PubMed ID: 18288745
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcatheter closure of patent foramen ovale, atrial septal defect and left atrial appendage.
    Majunke N; Wallenborn J; Wunderlich N; Sievert H
    Minerva Cardioangiol; 2009 Feb; 57(1):103-15. PubMed ID: 19202522
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Atrial septal pouch - Morphological features and clinical considerations.
    Hołda MK; Koziej M; Hołda J; Piątek K; Tyrak K; Chołopiak W; Bolechała F; Walocha JA; Klimek-Piotrowska W
    Int J Cardiol; 2016 Oct; 220():337-42. PubMed ID: 27390952
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PFO closure in 2008: See through a glass, darkly.
    Carroll JD
    Catheter Cardiovasc Interv; 2008 Feb; 71(3):388-9. PubMed ID: 18288736
    [No Abstract]   [Full Text] [Related]  

  • 58. Experience using the new GORE Septal Occluder at the margins.
    Lockhart CJ; Johnston NG; Spence MS
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1244-8. PubMed ID: 23418128
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Implantation of a Occlutech Figulla PFO occluder in a patient with patent foramen ovale and history of embolic stroke.
    Krecki R; Peruga JZ; Plewka M; Krzemińska-Pakuła M; Kasprzak JD
    Cardiol J; 2008; 15(4):380-2. PubMed ID: 18698549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Segmental atrial function following percutaneous closure of atrial septum using occluder device.
    Boyd AC; Cooper M; Thomas L
    J Am Soc Echocardiogr; 2009 May; 22(5):508-16. PubMed ID: 19307094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.